MRK
Merck & Company IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$269.66B
P/E Ratio
15.00
EPS
$7.28
Beta
0.28
52W High
$124.22
52W Low
$70.74
50-Day MA
$117.73
200-Day MA
$99.74
Dividend Yield
0.00%
Profit Margin
28.10%
Forward P/E
21.69
PEG Ratio
3.39
About Merck & Company Inc
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Fundamentals
| Revenue (TTM) | $65.01B |
| Gross Profit (TTM) | $50.20B |
| EBITDA | $29.11B |
| Operating Margin | 32.80% |
| Return on Equity | 36.90% |
| Return on Assets | 12.00% |
| Revenue/Share (TTM) | $25.98 |
| Book Value | $21.26 |
| Price-to-Book | 5.21 |
| Price-to-Sales (TTM) | 4.15 |
| EV/Revenue | 4.75 |
| EV/EBITDA | 10.93 |
| Quarterly Earnings Growth (YoY) | -19.30% |
| Quarterly Revenue Growth (YoY) | 5.00% |
| Shares Outstanding | $2.47B |
| Float | $2.47B |
| % Insiders | 0.06% |
| % Institutions | 81.32% |
Historical Volatility
HV 10-Day
32.84%
HV 20-Day
27.80%
HV 30-Day
25.87%
HV 60-Day
25.50%
HV Rank
43.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($129.74 target)
4
Strong Buy14
Buy11
HoldData last updated: 5/1/2026